전체 논문 (49편 · 1/2)
-
Correction: Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells.
-
CREB5 regulates stem cell-like transcriptional programs to enhance tumor progression in prostate cancer.
-
Retraction: Role of the PEBP4 protein in the development and metastasis of gastric cancer.
-
Retraction: By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
-
Retraction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
-
Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma.
-
Retraction: microRNA526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.
-
Retraction: miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
-
Retraction: Loss of FOXN3 in colon cancer activates beta-catenin/TCF signaling and promotes the growth and migration of cancer cells.
-
Retraction: LncRNA CHRFinduced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
-
Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism.
-
COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms.
-
Exploring the potential link between mRNA COVID-19 vaccinations and cancer: A case report with a review of haematopoietic malignancies with insights into pathogenic mechanisms.
-
Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
-
Cancer without borders: Policy frameworks for oncology care in humanitarian and conflict settings.
-
Bibliometric mapping of glioma classification research through main path, key route, and K-core analyses.
-
Efficacy and safety of PD-1/ PD-L1 inhibitors as adjuvants in the treatment of patients with solid cancers: A systematic review and meta-analysis of randomized controlled trials.
-
Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence.
-
Retraction: Up-regulation of microRNA let-7c by quercetin inhibits pancreatic cancer progression by activation of Numbl.
-
Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report.
-
Nerofe+ldDox releases c-Jun from nuclear ST2 to reprogram the immune microenvironment in mtKRAS tumors.
-
Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer.
-
Retraction: gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.
-
Retraction: MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2/STAT3-mediated EMT process.
-
Retraction: Androgen receptor promotes gastric cancer cell migration and invasion via AKT-phosphorylation dependent upregulation of matrix metalloproteinase 9.
-
Retraction: miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
-
Machine learning-based survival prediction in colorectal cancer combining clinical and biological features.
-
Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel therapy.
-
Correction: Real time chemosensitivity assay for pancreatic adenocarcinoma.
-
Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.